Open AccessRuxolitinib Is a Safe and Effective Therapeutic Option for Management of Chronic Gvhd - a Single Center Experience
Author(s) -
Rushang D. Patel,
Amy Lynn Browning,
Shahram Mori,
Juan Carlos Varela,
Steven C. Goldstein
Publication year - 2020
Publication title -
biology of blood and marrow transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.301
H-Index - 120
eISSN - 1523-6536
pISSN - 1083-8791
DOI - 10.1016/j.bbmt.2019.12.761
Subject(s) - ruxolitinib , medicine , concomitant , single center , retrospective cohort study , adverse effect , oncology , bone marrow , myelofibrosis
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom